Bicycle Therapeutics Ltd Capital Reinvestment Ratio

Latest as of June 2023: 0.01x

Bicycle Therapeutics Ltd capital reinvestment ratio. Bicycle Therapeutics Ltd (BCYC) has a Capital Reinvestment Ratio of 0.01x as of June 2023, meaning it reinvests 0% of its operating cash flow ($34.10 Million) in capital expenditures ($277.00K). Check BCYC cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

$34.10 Million

USD

Capital Expenditures

$277.00K

USD

Data as of

Jun 2023

Most recent filing

Bicycle Therapeutics Ltd Capital Reinvestment Ratio by Year (None–None)

Bicycle Therapeutics Ltd capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see cash efficiency ratio of Bicycle Therapeutics Ltd.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow